Japanese CRO Support Firm SRD Acquires Expartner Japan
This article was originally published in PharmAsia News
Tokyo-based Japanese contract research organization support company SRD acquires Expartner Japan, a Tokyo-based consulting company for outsourcing medical devices and related regulatory affairs. SRD has acquired 80 percent of EPJ shares. Through the acquisition, SRD hopes to develop a synergy by combining EPJ's expertise in medical devices, related regulatory affairs and approval application support, with its own business in CRO and site management organization support, as well as good laboratory practices testing facilities. According to SRD, the company hopes the synergy will bear fruit to a whole process support system to serve both domestic and overseas medical device makers. Along with a strengthened device support business, SRD also plans to enter the regenerative medicine support business area. (Click here for more - Japanese language
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.